Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)

v3.19.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2019
Jun. 30, 2018
Accounts receivable, allowance for doubtful accounts $ 1,037 $ 839
Deferred financing costs $ 360 $ 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 37,813,367 37,607,500
Common stock, shares outstanding (in shares) 37,813,367 37,607,500